204 related articles for article (PubMed ID: 582795)
41. Pharmacokinetics of brotizolam in healthy subjects following intravenous and oral administration.
Jochemsen R; Wesselman JG; Hermans J; van Boxtel CJ; Breimer DD
Br J Clin Pharmacol; 1983; 16 Suppl 2(Suppl 2):285S-290S. PubMed ID: 6661374
[TBL] [Abstract][Full Text] [Related]
42. Interaction between azapropazone and warfarin.
McElnay JC; D'Arcy PF
Br Med J; 1977 Sep; 2(6089):773-4. PubMed ID: 912313
[No Abstract] [Full Text] [Related]
43. Remoxipride--a new potential antipsychotic compound. Tolerability and pharmacokinetics after single oral and intravenous administration in healthy male volunteers.
Grind M; Nilsson MI; Nilsson L; Oxenstierna G; Sedvall G; Wahlén A
Psychopharmacology (Berl); 1989; 98(3):304-9. PubMed ID: 2568653
[TBL] [Abstract][Full Text] [Related]
44. Evaluation of the effect of azapropazone on neutrophil migration in anaesthetized swine using a multichamber blister suction technique.
Mousa SA; Brown R; Chan Y; Hsieh J; Smith RD
Br J Pharmacol; 1990 Feb; 99(2):233-6. PubMed ID: 2158370
[TBL] [Abstract][Full Text] [Related]
45. Kinetics of allopurinol after single intravenous and oral doses. Noninteraction with benzbromarone and hydrochlorothiazide.
Breithaupt B; Tittel M
Eur J Clin Pharmacol; 1982; 22(1):77-84. PubMed ID: 7094977
[TBL] [Abstract][Full Text] [Related]
46. Pharmacokinetics of paracetamol (acetaminophen) after intravenous and oral administration.
Rawlins MD; Henderson DB; Hijab AR
Eur J Clin Pharmacol; 1977 Apr; 11(4):283-6. PubMed ID: 862649
[TBL] [Abstract][Full Text] [Related]
47. Plasma protein binding of azapropazone in patients with kidney and liver disease.
Jähnchen E; Blanck KJ; Breuing KH; Gilfrich HJ; Meinertz T; Trenk D
Br J Clin Pharmacol; 1981 Apr; 11(4):361-7. PubMed ID: 7259929
[TBL] [Abstract][Full Text] [Related]
48. Disposition rate of proscillaridin A in man after multiple oral doses.
Bergdahl B
Arzneimittelforschung; 1979; 29(2):343-5. PubMed ID: 582147
[TBL] [Abstract][Full Text] [Related]
49. Pharmacokinetics and oral bioavailability of scopolamine in normal subjects.
Putcha L; Cintrón NM; Tsui J; Vanderploeg JM; Kramer WG
Pharm Res; 1989 Jun; 6(6):481-5. PubMed ID: 2762223
[TBL] [Abstract][Full Text] [Related]
50. Pharmacokinetic investigation of the interaction of azapropazone with phenytoin.
Geaney DP; Carver JG; Davies CL; Aronson JK
Br J Clin Pharmacol; 1983 Jun; 15(6):727-34. PubMed ID: 6871071
[TBL] [Abstract][Full Text] [Related]
51. Pharmacokinetics and bioavailability of viqualine, a new antidepressant.
Fourtillan JB; Bouquet S; Girault J; Lefebvre MA; Maulet C; Courtois P
Eur J Drug Metab Pharmacokinet; 1985; 10(1):3-10. PubMed ID: 4029218
[TBL] [Abstract][Full Text] [Related]
52. Pharmacokinetics of bolus intravenous and oral doses of L-carnitine in healthy subjects.
Harper P; Elwin CE; Cederblad G
Eur J Clin Pharmacol; 1988; 35(1):69-75. PubMed ID: 3220097
[TBL] [Abstract][Full Text] [Related]
53. Pharmacokinetics of hydralazine, apparent hydralazine and hydralazine pyruvic acid hydrazone in humans.
Shepherd AM; Ludden TM; Haegele KD; Talseth T; McNay JL
Res Commun Chem Pathol Pharmacol; 1979 Oct; 26(1):129-44. PubMed ID: 515498
[TBL] [Abstract][Full Text] [Related]
54. Pharmacokinetics of phenylethylmalonamide (PEMA) after oral and intravenous administration.
Pisani F; Richens A
Clin Pharmacokinet; 1983; 8(3):272-6. PubMed ID: 6851372
[TBL] [Abstract][Full Text] [Related]
55. The pharmacokinetics of amlodipine in healthy volunteers after single intravenous and oral doses and after 14 repeated oral doses given once daily.
Faulkner JK; McGibney D; Chasseaud LF; Perry JL; Taylor IW
Br J Clin Pharmacol; 1986 Jul; 22(1):21-5. PubMed ID: 2943308
[TBL] [Abstract][Full Text] [Related]
56. Oral and intravenous pharmacokinetics of milrinone in human volunteers.
Stroshane RM; Koss RF; Biddlecome CE; Luczkowec C; Edelson J
J Pharm Sci; 1984 Oct; 73(10):1438-41. PubMed ID: 6502494
[TBL] [Abstract][Full Text] [Related]
57. Pharmacokinetics of intravenous and oral bolus doses of L-carnitine in healthy subjects.
Harper P; Elwin CE; Cederblad G
Eur J Clin Pharmacol; 1988; 35(5):555-62. PubMed ID: 3234464
[TBL] [Abstract][Full Text] [Related]
58. Oral bioavailability and intravenous pharmacokinetics of amrinone in humans.
Park GB; Kershner RP; Angellotti J; Williams RL; Benet LZ; Edelson J
J Pharm Sci; 1983 Jul; 72(7):817-9. PubMed ID: 6886991
[TBL] [Abstract][Full Text] [Related]
59. Suramin as a chemosensitizer: oral pharmacokinetics in rats.
Ogden A; Wientjes MG; Au JL
Pharm Res; 2004 Nov; 21(11):2058-63. PubMed ID: 15587928
[TBL] [Abstract][Full Text] [Related]
60. [Plasma level of azapropazone during its combined administration with digitoxin].
Faust-Tinnefeldt G; Geissler HE; Gilfrich HJ
Med Welt; 1979 Feb; 30(5):181-2. PubMed ID: 310503
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
